Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PRME - Prime Medicine Inc

IEX Last Trade
4.29
-0.020   -0.466%

Share volume: 370,684
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$4.31
-0.02
-0.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-3.17%
1 Month
-21.18%
3 Months
-34.15%
6 Months
-53.38%
1 Year
-67.55%
2 Year
-72.15%
Key data
Stock price
$4.29
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$3.99 - $13.27
52 WEEK CHANGE
-$0.67
MARKET CAP 
513.732 M
YIELD 
N/A
SHARES OUTSTANDING 
120.031 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/01/2024
BETA 
2.45
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$385,626
AVERAGE 30 VOLUME 
$568,037
Company detail
CEO:
Region: US
Website:
Employees: 221
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news